Pages that link to "Q46433077"

The following pages link to Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis (Q46433077):

Displaying 32 items.

• The role of neurotrophins in multiple sclerosis-pathological and clinical implications (Q26849274) (← links)
• The mechanism of action of interferon-β in relapsing multiple sclerosis (Q28239752) (← links)
• Treatment of cognitive impairment in patients with multiple sclerosis (Q28272736) (← links)
• The measurement and clinical relevance of brain atrophy in multiple sclerosis (Q31030179) (← links)
• The effect of interferon-beta on black holes in patients with multiple sclerosis (Q31120372) (← links)
• Drug therapy for multiple sclerosis. (Q33990246) (← links)
• Targeting progressive neuroaxonal injury: lessons from multiple sclerosis. (Q34003724) (← links)
• The nerve growth factor signaling and its potential as therapeutic target for glaucoma (Q34182180) (← links)
• Evolving expectations around early management of multiple sclerosis (Q34409412) (← links)
• Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients (Q34482841) (← links)
• Retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-beta (Q34525419) (← links)
• Interferon β-1b and glatiramer acetate effects on permanent black hole evolution (Q34743156) (← links)
• Effects of glatiramer acetate and interferon-beta on neurodegeneration in a model of multiple sclerosis: a comparative study (Q35607258) (← links)
• What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis? (Q36396476) (← links)
• Review of the clinical evidence for interferon beta 1a (Rebif) in the treatment of multiple sclerosis (Q36842201) (← links)
• Interferon-beta treatment for multiple sclerosis (Q36963178) (← links)
• Longitudinal time-domain optic coherence study of retinal nerve fiber layer in IFNβ-treated and untreated multiple sclerosis patients (Q37001347) (← links)
• The role of neurotrophic factors in the pathology and treatment of multiple sclerosis (Q37269263) (← links)
• Early stage and long term treatment of multiple sclerosis with interferon-beta (Q37303237) (← links)
• The Inorganic Side of NGF: Copper(II) and Zinc(II) Affect the NGF Mimicking Signaling of the N-Terminus Peptides Encompassing the Recognition Domain of TrkA Receptor (Q37546022) (← links)
• A pilot study on the use of interferon beta-1a in early Alzheimer's disease subjects (Q37596887) (← links)
• Immunomodulatory drug treatment in multiple sclerosis (Q37785554) (← links)
• New findings and old controversies in the research of multiple sclerosis and its model experimental autoimmune encephalomyelitis (Q38103283) (← links)
• Interferon-β Inhibits Neurotrophin 3 Signalling and Pro-Survival Activity by Upregulating the Expression of Truncated TrkC-T1 Receptor. (Q39989941) (← links)
• Transient signaling of Erk1/2, Akt and PLCgamma induced by nerve growth factor in brain capillary endothelial cells. (Q43077626) (← links)
• Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis. (Q45998751) (← links)
• Multiple Sclerosis: Basic and Clinical. (Q47677846) (← links)
• Type I Interferons in NeuroHIV (Q59351777) (← links)
• Advances in the treatment of relapsing-remitting multiple sclerosis: the role of pegylated interferon β-1a. (Q64988430) (← links)
• Interferon-beta protects astrocytes against tumour necrosis factor-induced apoptosis via activation of p38 mitogen-activated protein kinase (Q81333268) (← links)
• Interferon-beta treatment normalises the inhibitory effect of serum from multiple sclerosis patients on oligodendrocyte progenitor proliferation (Q84979520) (← links)
• Nerve Growth Factor modulates LPS - induced microglial glycolysis and inflammatory responses (Q92008432) (← links)